InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（29 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
29
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Heyman Richard A., Director. Director active across 4 companies, notably Enliven Therapeutics, Inc.. In total, 34 disclosures have been logged. Breakdown: 0 buy · 29 sells. Total volume traded: €863k. History available since 11 May 2021. The latest transaction was disclosed on 24 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Heyman Richard A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报34 总计
3,500 股@ US$1.60Common StockSEC:0001584759-26-000015:0
7,000 股@ US$12.02Common StockSEC:0001584759-26-000015:1
6,100 股@ US$12.02Common StockSEC:0001584759-26-000015:2
300 股@ US$12.000.0005% mcap1.2% 占其流量Common StockSEC:0001584759-26-000012:0
1,230 股@ US$26.17594.9% 占其流量Common StockSEC:0001584759-26-000009:0
512 股@ US$26.45922.1% 占其流量Common StockSEC:0001584759-26-000007:0
3,500 股@ US$12.004616.9% 占其流量Common StockSEC:0001584759-26-000006:0
1,620 股@ US$25.000.0014% mcap50.0% 占其流量Common StockSEC:0001584759-26-000004:0
31,353 股@ US$1.6024.0% 占其流量Common StockSEC:0001584759-25-000004:0
817 股@ US$30.0034.1% 占其流量Common StockSEC:0001415889-24-025500:0
1,270 股@ US$27.67195.9% 占其流量Common StockSEC:0001415889-24-025381:0
2,825 股@ US$27.505712.8% 占其流量Common StockSEC:0001415889-24-024899:0
518 股@ US$27.53732.3% 占其流量Common StockSEC:0001415889-24-024668:0
1,270 股@ US$22.4084.7% 占其流量Common StockSEC:0001415889-24-023610:0
650 股@ US$22.81622.5% 占其流量Common StockSEC:0001415889-24-021644:0
1,702 股@ US$27.50597.9% 占其流量Common StockSEC:0001415889-24-020685:0
1,270 股@ US$24.80065.3% 占其流量Common StockSEC:0001415889-24-019731:0
1,270 股@ US$21.47874.6% 占其流量Common StockSEC:0001415889-24-017715:0
1,270 股@ US$23.73995.0% 占其流量Common StockSEC:0001415889-24-013833:0
5,045 股@ US$25.030621.4% 占其流量Common StockSEC:0001415889-24-010825:0
1,270 股@ US$14.50293.1% 占其流量Common StockSEC:0001415889-24-008883:0
367,446 股@ US$62.50100.0% 占其流量Common StockSEC:0001415889-24-005525:0
1,270 股@ US$17.41533.7% 占其流量Common StockSEC:0001415889-24-004495:0
1,270 股@ US$16.40913.5% 占其流量Common StockSEC:0001415889-24-002220:0
7 股@ US$13.000.0% 占其流量Common StockSEC:0001209191-23-059715:0
34 条申报中的 25 条
About Heyman Richard A.
Heyman Richard A. is a Director at Enliven Therapeutics, Inc., Oric Pharmaceuticals, Inc., RayzeBio, Inc. and PMV Pharmaceuticals, Inc. He has 31 filings in total, and across the sampled recent filings from 2021-05-13 to 2026-07-08, the reported amounts are entirely sales, totaling EUR 21949871.
